140 related articles for article (PubMed ID: 20501645)
1. Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer.
Nazarenko I; Jenny M; Keil J; Gieseler C; Weisshaupt K; Sehouli J; Legewie S; Herbst L; Weichert W; Darb-Esfahani S; Dietel M; Schäfer R; Ueberall F; Sers C
Mol Cancer Res; 2010 Jun; 8(6):919-34. PubMed ID: 20501645
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells.
Nazarenko I; Schäfer R; Sers C
J Cell Sci; 2007 Apr; 120(Pt 8):1393-404. PubMed ID: 17374643
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.
Fields AP; Regala RP
Pharmacol Res; 2007 Jun; 55(6):487-97. PubMed ID: 17570678
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G
Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413
[TBL] [Abstract][Full Text] [Related]
5. Characterization of PDK2 activity against protein kinase B gamma.
Hodgkinson CP; Sale EM; Sale GJ
Biochemistry; 2002 Aug; 41(32):10351-9. PubMed ID: 12162751
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.
Weichert W; Gekeler V; Denkert C; Dietel M; Hauptmann S
Int J Oncol; 2003 Sep; 23(3):633-9. PubMed ID: 12888898
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Mahanivong C; Chen HM; Yee SW; Pan ZK; Dong Z; Huang S
Oncogene; 2008 Feb; 27(9):1273-80. PubMed ID: 17724468
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
Huang WC; Chen JJ; Inoue H; Chen CC
J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.
Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK
BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.
Valledor AF; Xaus J; Comalada M; Soler C; Celada A
J Immunol; 2000 Jan; 164(1):29-37. PubMed ID: 10604989
[TBL] [Abstract][Full Text] [Related]
11. A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma.
Pillai P; Desai S; Patel R; Sajan M; Farese R; Ostrov D; Acevedo-Duncan M
Int J Biochem Cell Biol; 2011 May; 43(5):784-94. PubMed ID: 21315177
[TBL] [Abstract][Full Text] [Related]
12. PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.
Desai S; Pillai P; Win-Piazza H; Acevedo-Duncan M
Biochim Biophys Acta; 2011 Jun; 1813(6):1190-7. PubMed ID: 21419810
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C isoforms: Multi-functional regulators of cell life and death.
Reyland ME
Front Biosci (Landmark Ed); 2009 Jan; 14(6):2386-99. PubMed ID: 19273207
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
15. Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells.
Win HY; Acevedo-Duncan M
Cell Prolif; 2009 Apr; 42(2):182-94. PubMed ID: 19243387
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma induces gp91phox expression in human monocytes via protein kinase C-dependent phosphorylation of PU.1.
Mazzi P; Donini M; Margotto D; Wientjes F; Dusi S
J Immunol; 2004 Apr; 172(8):4941-7. PubMed ID: 15067074
[TBL] [Abstract][Full Text] [Related]
17. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
18. Atypical protein kinase C zeta as a target for chemosensitization of tumor cells.
Filomenko R; Poirson-Bichat F; Billerey C; Belon JP; Garrido C; Solary E; Bettaieb A
Cancer Res; 2002 Mar; 62(6):1815-21. PubMed ID: 11912160
[TBL] [Abstract][Full Text] [Related]
19. Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Ratnayake WS; Apostolatos AH; Ostrov DA; Acevedo-Duncan M
Int J Oncol; 2017 Nov; 51(5):1370-1382. PubMed ID: 29048609
[TBL] [Abstract][Full Text] [Related]
20. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition.
Alkan S; Huang Q; Ergin M; Denning MF; Nand S; Maududi T; Paner GP; Ozpuyan F; Izban KF
Am J Hematol; 2005 Jun; 79(2):97-106. PubMed ID: 15929099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]